Virtu Financial’s Liminal BioSciences Inc. Common Shares LMNL Stock Holding History

Virtu Financial’s Portfolio LMNL Stock Details LMNL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,855	Closed	-$20K	–	2281
2021 Q4	$20K	Sell	1,855 -777	-30%	-$11.6K	﹤0.01%	1516
2021 Q3	$60K	Buy	2,632 +1,280	+95%	+$36.9K	0.01%	1244
2021 Q2	$53K	Sell	1,352 -911	-40%	-$39.7K	0.01%	1332
2021 Q1	$93K	Sell	2,263 -1,264	-36%	-$61.4K	0.01%	1339
2020 Q4	$148K	Buy	3,527 +2,050	+139%	+$112K	0.02%	948
2020 Q3	$164K	Buy	+1,477	New	+$200K	0.03%	633

Other funds holding LMNL

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ECM

Estabrook Capital Management New York $685M AUM 26.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Virtu Financial's LMNL Position: Q1 2022 in Review

Virtu Financial sold out of Liminal BioSciences Inc. Common Shares (LMNL) in Q1 2022, closing a stake of 1,855 shares — an estimated $20K sold.

Virtu Financial first reported a position in LMNL in Q3 2020 and held it in 6 quarters. The position peaked at $164K in Q3 2020. 18 funds tracked by Wall St. Rank hold LMNL as of Q1 2022.

Virtu Financial reported no remaining Liminal BioSciences Inc. Common Shares position as of Q1 2022 after selling out during the quarter.
Virtu Financial sold 1,855 Liminal BioSciences Inc. Common Shares shares in Q1 2022, an estimated $20K.
Virtu Financial first reported a position in Liminal BioSciences Inc. Common Shares in Q3 2020 and held it in 6 quarters.
Virtu Financial's Liminal BioSciences Inc. Common Shares position peaked at $164K in Q3 2020.
18 funds tracked by Wall St. Rank held Liminal BioSciences Inc. Common Shares as of Q1 2022.

Based on Virtu Financial's 13F filing for Q1 2022, filed 17 May 2022.